Form 4: eHealth Director Beth Brooke Receives Annual Equity Award of Restricted Stock Units

eHealth, Inc. Director Beth A. Brooke was granted 34,574 shares of common stock in the form of Restricted Stock Units as part of her annual compensation, aligning her interests with shareholders.

Summary

• Beth A. Brooke, a Director of eHealth, Inc. (EHTH), acquired 34,574 shares of common stock on June 17, 2025.
• The acquisition was an annual award of Restricted Stock Units (RSUs) to non-employee directors, with a reported transaction price of $0 per share.
• Each RSU represents a contingent right to receive one share of eHealth's common stock upon vesting.
• The RSUs will vest in four equal quarterly installments, commencing from June 17, 2025.
• Vesting is contingent on Ms. Brooke's continued status as a Service Provider, as defined in the Issuer's 2024 Equity Incentive Plan.
• Accelerated vesting will occur on the day immediately prior to the Issuer's next annual stockholder meeting or if the Issuer is subject to a Change in Control, subject to continued service.
• Following this transaction, Ms. Brooke beneficially owns 132,833 shares of eHealth common stock directly.

Sentiment

Score: 6

Explanation: The document reports a routine insider transaction related to director compensation, which is generally a neutral to slightly positive event as it aligns director interests with shareholders. It does not contain information that would significantly alter the company's financial outlook or operational status.

Positives

• The award of Restricted Stock Units to Director Beth A. Brooke aligns her interests directly with those of eHealth shareholders, as the value of her compensation is tied to the company's stock performance.
• This is a standard annual equity award for non-employee directors, indicating a routine and established compensation practice under the company's 2024 Equity Incentive Plan.

Future Outlook

The Restricted Stock Units are scheduled to vest in four equal quarterly installments from June 17, 2025, with potential accelerated vesting upon the company's next annual stockholder meeting or a Change in Control, subject to continued service.

Industry Context

The granting of Restricted Stock Units to non-employee directors is a common practice across publicly traded companies, particularly in the healthcare and technology sectors, to attract and retain qualified board members and align their long-term interests with shareholder value.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a component of non-employee director compensation is a widely adopted practice among U.S. public companies, including those in the health insurance marketplace and technology sectors like eHealth.
• The vesting schedule, typically over one year or tied to the next annual meeting, is also standard, ensuring continued engagement and oversight from board members.
• While specific comparable companies (e.g., SelectQuote, GoHealth) are not mentioned in the filing, their compensation structures for non-employee directors often include similar equity-based awards to promote long-term alignment.

Stakeholder Impact

• Shareholders: The equity award aligns the director's financial interests with shareholder value, as the value of the RSUs is tied to the company's stock performance.
• Employees: No direct impact mentioned, but the company's equity incentive plan supports broader compensation strategies.

Next Steps

• The Restricted Stock Units will vest in four equal quarterly installments starting June 17, 2025.
• Potential accelerated vesting may occur prior to the Issuer's next annual stockholder meeting or upon a Change in Control.

Key Dates

Keywords

eHealth, EHTH, SEC Form 4, Insider Transaction, Director Compensation, Restricted Stock Units, RSU Award, Equity Incentive Plan, Corporate Governance